Last updated: September 6, 2023
Sponsor: Sonova AG
Overall Status: Active - Recruiting
Phase
N/A
Condition
Deafness
Hearing Impairment
Hearing Loss
Treatment
hearing aid - standard program
hearing aid -novel program
Clinical Study ID
NCT05561335
5251
Ages 18-99 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Subjects fulfilling all of the following inclusion criteria are eligible for theinvestigation:
- Including adults with sensorineural mild to moderate-severe hearing loss
- hearing aid experience (greater than 6 months)
- who are able to complete the task in English.
- Language: Can speak and understand English Fluently Hearing loss within the fitting ranges of the investigational products.
- Healthy outer ear.
- Ability to understand instructions.
- Ability to describe listening experiences.
- Ability to fill out questionnaires.
- Informed consent as documented by signature.
Exclusion
Exclusion Criteria:
- The presence of any one of the following exclusion criteria will lead to the exclusion ofthe subject:
- Contraindications to the MD in this study (e.g. known hypersensitivity or allergy tothe investigational product).
- Limited mobility and not able to attend to appointments or not able to go in a car.
- Reported symptoms of vertigo and dizziness by subject.
- Severe Tinnitus
Study Design
Total Participants: 20
Treatment Group(s): 2
Primary Treatment: hearing aid - standard program
Phase:
Study Start date:
March 21, 2023
Estimated Completion Date:
October 31, 2023
Study Description
Connect with a study center
Western University
London, Ontario N6G 1G9
CanadaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.